high dose oral semaglutide In the OASIS 4 phase 3 trial, once-daily at a of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or High doses of oral semaglutide

Each comparison reinforces that semaglutide occupies a favorable position in the risk-benefit calculation for cardiovascular impact among weight management medications

Weight Loss Maintenance Program: Stay on Track for Life Maintaining weight loss is often harder than losing it

Some heart conditions that can increase your risk include: Arrhythmias (Irregular Heartbeats): People with atrial fibrillation (AFib) or other rhythm disorders may feel their heartbeat change more often when taking new medications

Clinical trials showed that about 3% of people on the 0.5 mg dose and around 1% of those on the 1 mg dose reported experiencing this side effect